Skip to main content
Fig. 5 | Cardiovascular Diabetology

Fig. 5

From: Real-world characteristics, modern antidiabetic treatment patterns, and comorbidities of patients with type 2 diabetes in central and Eastern Europe: retrospective cross-sectional and longitudinal evaluations in the CORDIALLY® study

Fig. 5

T2D study medication use in patients with and without A CVD and B CKD at baseline (Prescribed Patient Set). CVD, cardiovascular disease; CKD, chronic kidney disease; DPP4i, dipeptidyl peptidase-4 inhibitor; GLP-1 RA, glucagon-like peptide-1 receptor agonist; HCP, healthcare professional; SGLT2i, sodium-glucose cotransporter-2 inhibitor

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840